Press "Enter" to skip to content

New patent expiration for Kastle Theraps drug KYNAMRO


Annual Drug Patent Expirations for KYNAMRO
Annual Drug Patent Expirations for KYNAMRO

Kynamro is a drug marketed by Kastle Theraps Llc
and is included in one NDA. It is available from two suppliers. There are six patents protecting this drug.

This drug has five hundred and sixty patent family members in twenty-six countries.

The generic ingredient in KYNAMRO is mipomersen sodium. Two suppliers are listed for this compound. Additional details are available on the mipomersen sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!